ArticleCureus2025
Solitary Brain Lesion: An Unexpected Presentation of Urachal Adenocarcinoma.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Urachal adenocarcinoma (UA) is a rare and aggressive malignancy that typically presents at advanced stages and is associated with poor prognosis. We describe the case of a 63-year-old man with a history of UA treated with partial cystectomy seven years earlier, who remained under annual oncologic follow-up, with the last assessment nine months before the current episode. He presented with neurological symptoms initially suggestive of ischemic stroke. Brain magnetic resonance imaging (MRI) revealed a left cerebellar lesion, and due to its symptomatic nature and diagnostic uncertainty, surgical resection was performed. The biopsy showed metastatic adenocarcinoma, without definitive identification of the primary site. Subsequent staging identified only pulmonary lesions suggesting lung cancer; however, the diagnosis was made after a transthoracic needle biopsy, which confirmed UA in an advanced stage. The patient underwent whole-brain radiotherapy followed by systemic chemotherapy with fluoropyrimidine and platinum. Despite disease progression, he achieved prolonged disease control and preserved quality of life, living more than one year with an Eastern Cooperative Oncology Group (ECOG) performance status of 1 until the final weeks of life. This case shows that UA may present with late brain metastasis and supports a multidisciplinary treatment approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.